Adalimumab biosimilar (Lg Chemical)

阿达木单抗生物类似药（Lg Chemical）

Report date: 2024/12/13 15:33:49

Base Information

Drug NameAdalimumab biosimilar (Lg Chemical)
Drug Alias Nameアダリムマブ（遺伝子組換え）（持田製薬株式会社）阿达木单抗生物仿制药（Lg Chemical）XelenkaLBAL
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsPlaque psoriasisNon-radiographic axial spondyloarthritisPsoriasis +[15] 
Global Approved IndicationsPsoriasisUveitis, IntermediateUveitis, Posterior +[11] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2021/03/23
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical LtdMochda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisNon-radiographic axial spondyloarthritisPsoriasis +[15] 
Inactive IndicationsN/A

Other Information

ATC CodeL04AB04
Related LinksN/A